Reliability of Artificial Intelligence (AI)-Augmented Point-of-care Cardiac Ultrasound in the Hands of Internists
Launched by SHEBA MEDICAL CENTER · Jul 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well internists (doctors who specialize in internal medicine) can use a new artificial intelligence (AI) tool to help them interpret cardiac ultrasound images. The goal is to see if this AI support can improve the accuracy of diagnosing heart conditions, especially in patients with cardiovascular diseases and valvular heart disease. To determine how well the internists perform, the ultrasound images will also be reviewed by cardiologists who specialize in these types of exams.
To participate in the trial, patients should have a medically necessary cardiac ultrasound that their doctor recommends, and they need to be able to give consent for the procedure. It’s important that they do not have any urgent health issues that require immediate, more detailed testing. The study is currently looking for up to 1,000 patients, with most coming from internal medicine and some from a geriatric unit. Participants can expect a short ultrasound exam, and the study aims to help improve heart care for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinically indicated POCUS cardiac assessment as determined by the treating physicians for an accepted clinical indication
- • 2. Willing and able to provide consent for a short partial transthoracic POCCUS examinations
- • 3. No urgent or other compelling need for a comprehensive echo exam by the echo lab.
- Exclusion Criteria:
- • 1. Unstable clinical condition that does not permit any reasonable delay necessary to obtain consent and perform the POCCUS
- • 2. Severe thoracic deformation or thoracic wall infection or wound that does not permit an adequate echocardiographic examination
- • 3. Very poor or non-diagnostic echocardiographic imaging quality on prior echocardiography examinations.
- • 4. Patients after lung resection
- • 5. Patients unable lie in bed and undergo a standard echo study
- • 6. Participation in an interventional study
About Sheba Medical Center
Sheba Medical Center, located in Israel, is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, Sheba Medical Center leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and developing novel therapeutic interventions. The center's collaborative environment fosters partnerships with global research organizations, enhancing its ability to contribute to the scientific community and drive medical advancements across various fields. With a strong focus on patient safety and ethical standards, Sheba Medical Center is dedicated to translating research findings into practical applications that benefit patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ramat Gan, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials